step 9 semaglutide The weight loss drug is doing something else. And your doctor probably missed it. The New England Journal of Medicine just published the trial — given to patients with Weight Loss: Semaglutide May Help

The initiative is part of LifeMDs collaboration with Novo Nordisk, announced last month, and leverages a recently completed integration with NovoCare Pharmacy to offer Wegovy at a discounted price of $199 for eligible patients, with an additional $100 covering LifeMDs clinical care, onboarding, and ongoing support

households had at least one GLP-1 user in the family as of September 2025

RELATED: NAD+ Therapy Explained: Do Injections and Supplements Really Work for Longevity

Hazard ratios (HRs) at 1, 3, and 5-year follow-up periods were calculated using Cox proportional hazards analysis

"It's an exciting moment after decades of unsuccessful attempts to find effective treatments for people living with obesity." Concerns About Industry Funding and Access A large share of the studies included in the reviews were funded by the companies that manufacture the drugs